Skip to main content

Zoetis Inc Cl A(ZTS-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low118.28
Day High121.87
Open:121.02
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Zoetis Inc Cl A

Select a category then submit the form to load news
Tipranks
Bank of America Securities Reaffirms Their Hold Rating on Zoetis (ZTS)
Zacks Investment Research
Zacks.com featured highlights include Ross Stores, Globe Life, Banco Bilbao, Zoetis and TE Connectivity
Zacks.com featured highlights include Ross Stores, Globe Life, Banco Bilbao, Zoetis and TE Connectivity
Zacks Investment Research
Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune
Buy 5 Stocks With High ROE as Markets Dance Whimsically to the AI Tune
Tipranks
Zoetis (ZTS) Receives a Buy from BTIG
StockStory
2 Reasons to Like ZTS (and 1 Not So Much)
ZTS
Tipranks
Bank of America Securities Sticks to Their Hold Rating for Zoetis (ZTS)
Motley Fool
2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200
Tipranks
Stifel Nicolaus Reaffirms Their Hold Rating on Zoetis (ZTS)
Tipranks
Zoetis (ZTS) Gets a Buy from Morgan Stanley
StockStory
The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call
ZTS
StockStory
2 S&P 500 Stocks to Research Further and 1 We Question
WM
StockStory
3 S&P 500 Stocks Worth Investigating
TT
Tipranks
Zoetis Earnings Call: Growth Holds Amid Competitive Strain
Tipranks
Zoetis’ Convertible Notes Trigger Liquidity and Reporting Risks if Conditional Conversion Kicks In
Tipranks
Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS), Humana (HUM) and 10x Genomics (TXG)
StockStory
ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook
ZTS
Motley Fool
Zoetis (ZTS) Q4 2025 Earnings Call Transcript
StockStory
Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates
ZTS
StockStory
Zoetis (ZTS) Reports Q4: Everything You Need To Know Ahead Of Earnings
ZTS
Motley Fool
Should You Buy Zoetis Before Feb. 12?
Tipranks
Zoetis Board Declares Second-Quarter 2026 Cash Dividend
StockStory
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore
EYE
Tipranks
Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS) and Resmed (RMD)
Tipranks
Alphabet upgraded, Micron initiated: Wall Street’s top analyst calls
Motley Fool
2 Healthcare Stocks Poised for a Comeback in 2026
Motley Fool
This Could Be One of the Best Healthcare Stock Buying Opportunities I've Seen in Years
StockStory
Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment
ZTS
Tipranks
Zoetis (ZTS) Gets a Hold from Stifel Nicolaus
StockStory
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Challenges
CDNS
StockStory
1 Profitable Stock with Solid Fundamentals and 2 We Brush Off
ARW
StockStory
2 Safe-and-Steady Stocks with Competitive Advantages and 1 We Turn Down
LOPE
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zoetis (ZTS), Enovis (ENOV) and Icon (ICLR)

Profile

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.